Yet, at concentrations known to specifically inhibit MET phosphorylation (Fig. 1E), tepotinib failed to sensitize glioma cells to the inhibitory effects of irradiation in vitro (Fig. 2C). This evidence concerns the gene MET and central nervous system cancer.